Workflow
推理算力需求爆发 七牛智能卡位AI Cloud或迎量价双增
Zhi Tong Cai Jing· 2025-09-12 04:56
Group 1 - The core focus is on the AI inference market, which is identified as a trillion-dollar opportunity, with a significant increase in remaining performance obligations (RPO) reaching $455 billion [1] - AI inference is characterized as a continuous demand that will be utilized across various scenarios, contrasting with the periodic and resource-intensive nature of AI training [1] - Qiniu Intelligent reported AI-related revenue of 184 million yuan, contributing 22.2% to total revenue, with a notable increase in AI users reaching 15,000 due to the availability of over 50 callable large models [1] Group 2 - Meeting AI inference demand requires reducing end-to-end latency and increasing throughput in production environments, with inference compute needs surpassing training requirements [2] - High-quality, accessible enterprise data is essential for providing actionable insights from inference models, making structured data assets a key resource for entering the "inference era" [2] - Qiniu Intelligent's past 14 years of experience in audio and video cloud services has equipped it with low-latency, high-throughput global real-time nodes and vast storage capabilities, positioning it favorably in the AI cloud service growth curve [2]
推理算力需求爆发 七牛智能(02567)卡位AI Cloud或迎量价双增
智通财经网· 2025-09-12 04:54
Group 1 - The core opportunity in the AI market lies in AI inference, which is expected to be a trillion-dollar market, as highlighted by Oracle founder Larry Ellison [1] - Oracle's remaining performance obligations (RPO) surged to $455 billion, indicating strong future revenue potential [1] - AI training is resource-intensive and cyclical, while AI inference represents a continuous demand for resources, driving sustained growth in AI cloud services [1] Group 2 - Qiniu Intelligent reported AI-related revenue of 184 million yuan, accounting for 22.2% of total revenue, with a user base exceeding 15,000 [2] - The company's AI revenue is primarily derived from AI inference services and computing resources, with over 50 callable large models available [2] - To meet AI inference demands, companies must reduce end-to-end latency and improve throughput under high request pressure, necessitating high-quality enterprise data [2] Group 3 - Qiniu Intelligent leverages its 14 years of experience in audio and video cloud services to enhance its AI cloud services, focusing on low latency and high throughput [3] - The company occupies a dual position in the value chain by providing upstream data and midstream computing infrastructure, leading to long-term revenue growth from inference computing [3] - The integration of private audio and video heterogeneous data into inference models is crucial for the company's growth in AI services [3]
泡泡玛特旗下popop涉足黄金市场,挑战传统金舖!首推足金产品最贵单品重41克售价超5.6万
Ge Long Hui· 2025-09-12 04:51
有媒体称,首阶段将推旗下IP产品Baby Molly,包括黄金串珠、吊坠、金条和摆件,价格介乎980至5.68万 元。popop店员表示,该系列新品非限定产品,价格不会按照金价浮动,而是据工艺不同而定,足金系列 产品每克单价主要集中在1300-1700元。 据悉,popop单价较泡泡玛特早前联名金饰略低,如以泡泡玛特与周生生推出的"周游奇梦"(Dimoo World) 系列,约0.8克的DIMOO黄金串珠售价约1743元,单克价格约2179元。并与老铺黄金一样,popop并没有 设"金价+加工费"定价策略,产品均是一口价。 (责任编辑:宋政 HN002) 【免责声明】本文仅代表作者本人观点,与和讯网无关。和讯网站对文中陈述、观点判断保持中立,不对所包含内容的 准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考,并请自行承担全部责任。邮箱: news_center@staff.hexun.com 格隆汇9月12日|泡泡玛特饰品品牌popop涉足黄金市场挑战传统金舖。据悉,将首次推出足金系列产品, 最贵单品是约重41克的黄金摆件,售价超过5.6万元。 ...
赛晶科技:赛晶半导体与三安半导体签订战略合作框架协议
人民财讯9月12日电,赛晶科技在港交所公告,9月12日,公司旗下子公司赛晶亚太半导体科技(浙江) 有限公司(简称"赛晶半导体")与湖南三安半导体有限责任公司(简称"三安半导体")签订战略合作框 架协议,正式建立全面战略合作伙伴关系。赛晶半导体主要从事研发及制造功率半导体器件。三安半导 体是三安光电(600703)的全资子公司,拥有碳化硅全产业链垂直整合制造服务平台。目前,三安半导体 的8英寸碳化硅芯片产线已通线。 三安半导体将根据赛晶半导体的需求,确保稳定及时地向赛晶半导体供应产品;赛晶半导体在三安半导 体的生产计划中享有优先供应权。双方将共同评估市场增长潜力,制订产能扩展计划。 转自:证券时报 ...
恒大物业复牌,股价大涨!
Zheng Quan Shi Bao· 2025-09-12 04:45
Core Viewpoint - Evergrande Property has received a letter from the liquidators of China Evergrande Group and CEG Holdings regarding the potential sale of its shares, indicating ongoing efforts to find buyers for the company [1] Group 1: Company Developments - On September 10, 2025, Evergrande Property received a letter from the liquidators seeking opportunities to sell shares held by China Evergrande and CEG Holdings [1] - The liquidators have signed confidentiality agreements with interested parties and received non-binding indicative offers from some of them as of September 9 [1] - Evergrande Property's stock was suspended on September 11, 2025, and resumed trading on September 12, opening high and reaching a peak increase of 38% before closing with over a 30% gain [1] Group 2: Market Context - In August 2023, it was reported that the liquidators of China Evergrande Group hired UBS and CITIC Securities to find potential buyers for Evergrande Property, with rumors of interest from subsidiaries of China Resources Group, which were denied by China Resources Land [2] - Several real estate companies have been selling their property management stakes to alleviate financial pressures, with a recent example being the sale of property management business by Shui On Land for HKD 100 million [3] - Property management is viewed as a light-asset and stable cash-generating business, making it attractive for companies to sell in the current market environment [3] Group 3: Financial Performance - Evergrande Property reported a revenue of approximately CNY 6.647 billion for the first half of 2025, a year-on-year increase of about 6.9%, with a net profit of approximately CNY 491 million [4] - The net profit margin was approximately 7.4%, a decrease of about 0.6 percentage points year-on-year, with cash and cash equivalents amounting to approximately CNY 2.778 billion [4] - As of June 30, 2025, the total managed area was approximately 596 million square meters, an increase of about 41 million square meters from the previous year, although the conversion of signed projects from related parties is currently stalled [4]
2025年职场人健康养生行为大赏报告-微博&克劳锐
Sou Hu Cai Jing· 2025-09-12 04:43
今天分享的是:2025年职场人健康养生行为大赏报告-微博&克劳锐 报告共计:25页 《2025年职场人健康养生行为大赏报告》由微博与克劳锐联合发布,聚焦职场人健康养生现状、行为及未来趋势。当下职场 人面临严峻健康挑战,近九成受健康问题困扰,颈椎病、结节、脱发为三大痛点,30-35岁职场人健康自评分最低却体检频次 最高,且职场压力显著,38.7%职场人几乎每天加班,40.1%经历"隐形加班",加班导致62.5%职场人情绪问题增加、60.8%健 康受饮食睡眠干扰。同时,职场人还承担家庭健康责任,尤其独生子女家庭"421"结构下,职场父母需兼顾子女抚养教育与父 母赡养。在此背景下,职场人健康意识觉醒,"预防大于治疗"成共识,2024年微博健康科普类热搜话题占比同比增181%,中 医保健类增40%,健康社交也发挥正向作用,超1/4民众愿参与运动社交,各类健康打卡话题热度高,职场人还分享体检报 告、交流健康心得,健康管理向前置化、生活化转变,行动上中西并举,兼顾饮食控制与滋补调理。报告还解析职场人健康 需求进阶,从固本级(日常科普与疾病预防,如专家分享办公健康隐患应对、季节性防护)、智养级(科学调养,如碎片运 动、补品 ...
恒大物业复牌大涨,中海华润回应恒大物业相关传言
Di Yi Cai Jing· 2025-09-12 04:38
【#恒大物业复牌大涨#,#中海华润回应恒大物业相关传言#】在历经短暂停牌后,9月12日,恒大物业 (06666.HK)复牌高开超38%。随后股价出现回调,截至发稿,报1.18港元,涨幅约28.26%,总市值约 127.57亿港元。 市场兴奋的背后是恒大物业再次找到买方。9月11日晚,恒大物业公告称,收到控股股东中国恒大及 CEGHoldings清盘人发来的接洽函称,清盘人一直寻求机会出售中国恒大及CEGHoldings所持的恒大物 业股份。目前,恒大方面直接或间接持有恒大物业已发行股本的51.016%。 有市场消息称,有意接手方包括央企中海和华润。就此,第一财经记者向两家公司求证,华润置地方面 表示,该消息不属实;中海方面称,目前还不掌握相关情况。 ...
2025财年毛利率65.6%,江南布衣2026财年百亿零售目标不变
Tai Mei Ti A P P· 2025-09-12 04:38
Core Viewpoint - Jiangnan Buyi maintains its target of achieving 10 billion in retail by fiscal year 2026, focusing on domestic market expansion while viewing overseas markets as long-term opportunities for brand influence and lifestyle globalization [2][3]. Financial Performance - For the fiscal year 2025, Jiangnan Buyi reported total revenue of approximately RMB 5.548 billion, a year-on-year increase of about 4.6% [2]. - The company's gross profit reached RMB 3.64 billion, with a stable gross margin exceeding 65% [2]. - Net profit for the fiscal year was approximately RMB 897 million, reflecting a 6% year-on-year growth, resulting in a net profit margin of 16.2%, surpassing previous expectations [3][4]. Sales Channels - Online sales grew by 18.3% to RMB 1.201 billion, while the overall retail network expanded to 2,117 stores globally, covering all provinces in mainland China and 10 other countries [6][7]. - The contribution of online sales to total revenue surpassed 20% for the first time [7][8]. Multi-Brand Strategy - Jiangnan Buyi operates a multi-brand strategy with three tiers: mature brands, growth brands, and emerging brands, covering various segments including menswear, womenswear, and children's wear [4]. - The mature brand JNBY accounted for 54.3% of total revenue, while emerging brands generated RMB 361 million, a 107.4% increase year-on-year [4][5]. Operational Strategy - The company plans to enhance its retail network and optimize its direct sales team for better operational efficiency, focusing on key cities [5][8]. - Jiangnan Buyi aims to improve its supply chain and inventory structure through a shared inventory system and plans to establish a more intelligent distribution center [9]. Membership and Customer Engagement - Active membership accounts increased to over 560,000, contributing more than 80% of total retail revenue, with members spending over RMB 5,000 also rising to over 330,000 [8][9]. - The company is enhancing member benefits and experiences to drive further growth in online sales [8].
港股午评:恒指涨1.53%阶段新高,科技股强势有色金属股活跃!阿里巴巴涨6%,百度集团涨8%,京东、快手涨3%
Ge Long Hui· 2025-09-12 04:30
【免责声明】本文仅代表作者本人观点,与和讯网无关。和讯网站对文中陈述、观点判断保持中立,不对所包含内容 的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考,并请自行承担全部责任。邮箱: news_center@staff.hexun.com 盘面上,大型科技股表现强势带领大市造好,据报用自研芯片训练AI模型,百度大涨8.54%、阿里巴巴 涨近6%,网易、腾讯、京东、快手涨近3%,小米、美团皆有涨幅;初请数据力证就业市场疲软,美联 储降息押注急速加码,有色金属股集体活跃,铜业股涨幅明显,江西铜业(600362)股份盘中涨近9%刷新 历史新高;内房股拉升,远洋集团领衔上涨,临近午盘钢铁股异动拉升,重庆钢铁(601005)股份涨约 7%;昨日大幅下挫的创新药概念股集体回暖,脑机接口概念股、重型机械股、手游股、建材水泥股、 纸业股、内险股纷纷上涨。 另一方面,香港本地消费股走低,苹果概念股、煤炭股、石油股、光伏股多数低迷,其中,昨日大涨近 13%的鸿腾精密跌超5%,新特能源、中国神华(601088)、中国石油(601857)股份均下跌。(格隆汇) (责任编辑:宋政 HN002) 格隆汇9月12日|港股上 ...
维立志博-B(09887):LBL-024于奥帕替苏米单抗黑色素瘤Ib/Ⅱ期试验的首例患者成功用药
智通财经网· 2025-09-12 04:29
Core Viewpoint - The announcement from Valiant Biopharma-B (09887) highlights the initiation of a Phase Ib/II clinical trial for the drug Opalizumab (PD-L1/4-1BB bispecific antibody LBL-024) in treating advanced melanoma, marking a significant step in cancer therapy development [1] Group 1 - The Phase Ib/II multi-center clinical trial is led by Professor Chen Yu from Fujian Cancer Hospital, with participation from multiple hospitals across the country [1] - The trial aims to evaluate the efficacy and safety of Opalizumab as a monotherapy or in combination with other agents for the treatment of advanced melanoma [1]